Delays in diagnosis and treatment of breast cancer

A multinational analysis

Jacek Jassem, Vahit Ozmen, Florin Bacanu, Monika Drobniene, Janis Eglitis, Kuntegowdanahalli C. Lakshmaiah, Z. Kahán, Jozef Mardiak, Tadeusz Pieńkowski, Tatiana Semiglazova, Ljiljana Stamatovic, Constanta Timcheva, Suzana Vasovic, Damir Vrbanec, Piotr Zaborek

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Background: Reducing treatment delay improves outcomes in breast cancer. The aim of this study was to determine factors influencing patient- and system-related delays in commencing breast cancer treatment in different countries. Methods: A total of 6588 female breast cancer patients from 12 countries were surveyed. Total delay time was determined as the sum of the patient-related delay time (time between onset of the first symptoms and the first medical visit) and system-related delay time (time between the first medical visit and the start of therapy). Results: The average patient-related delay time and total delay time were 4.7 (range: 3.4-6.2) weeks and 14.4 (range: 11.5-29.4) weeks, respectively. Longer patient-related delay times were associated with distrust and disregard, and shorter patient-related delay times were associated with fear of breast cancer, practicing self-examination, higher education level, being employed, having support from friends and family and living in big cities. The average system-related delay time was 11.1 (range: 8.3-24.7) weeks. Cancer diagnosis made by an oncologist versus another physician, higher education level, older age, family history of female cancers and having a breast lump as the first cancer sign were associated with shorter system-related delay times. Longer patient-related delay times and higher levels of distrust and disregard were predictors of longer system-related delay times. Conclusions: The delay in diagnosis and treatment of breast cancer remains a serious problem. Several psychological and behavioural patient attributes strongly determine both patient-related delay time and system-related delay time, but their strength is different in particular countries.

Original languageEnglish
Pages (from-to)761-767
Number of pages7
JournalEuropean Journal of Public Health
Volume24
Issue number5
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Breast Neoplasms
Therapeutics
Self-Examination
Education
Neoplasms
Fear
Breast
Psychology
Physicians

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Medicine(all)

Cite this

Jassem, J., Ozmen, V., Bacanu, F., Drobniene, M., Eglitis, J., Lakshmaiah, K. C., ... Zaborek, P. (2014). Delays in diagnosis and treatment of breast cancer: A multinational analysis. European Journal of Public Health, 24(5), 761-767. https://doi.org/10.1093/eurpub/ckt131

Delays in diagnosis and treatment of breast cancer : A multinational analysis. / Jassem, Jacek; Ozmen, Vahit; Bacanu, Florin; Drobniene, Monika; Eglitis, Janis; Lakshmaiah, Kuntegowdanahalli C.; Kahán, Z.; Mardiak, Jozef; Pieńkowski, Tadeusz; Semiglazova, Tatiana; Stamatovic, Ljiljana; Timcheva, Constanta; Vasovic, Suzana; Vrbanec, Damir; Zaborek, Piotr.

In: European Journal of Public Health, Vol. 24, No. 5, 01.10.2014, p. 761-767.

Research output: Contribution to journalArticle

Jassem, J, Ozmen, V, Bacanu, F, Drobniene, M, Eglitis, J, Lakshmaiah, KC, Kahán, Z, Mardiak, J, Pieńkowski, T, Semiglazova, T, Stamatovic, L, Timcheva, C, Vasovic, S, Vrbanec, D & Zaborek, P 2014, 'Delays in diagnosis and treatment of breast cancer: A multinational analysis', European Journal of Public Health, vol. 24, no. 5, pp. 761-767. https://doi.org/10.1093/eurpub/ckt131
Jassem J, Ozmen V, Bacanu F, Drobniene M, Eglitis J, Lakshmaiah KC et al. Delays in diagnosis and treatment of breast cancer: A multinational analysis. European Journal of Public Health. 2014 Oct 1;24(5):761-767. https://doi.org/10.1093/eurpub/ckt131
Jassem, Jacek ; Ozmen, Vahit ; Bacanu, Florin ; Drobniene, Monika ; Eglitis, Janis ; Lakshmaiah, Kuntegowdanahalli C. ; Kahán, Z. ; Mardiak, Jozef ; Pieńkowski, Tadeusz ; Semiglazova, Tatiana ; Stamatovic, Ljiljana ; Timcheva, Constanta ; Vasovic, Suzana ; Vrbanec, Damir ; Zaborek, Piotr. / Delays in diagnosis and treatment of breast cancer : A multinational analysis. In: European Journal of Public Health. 2014 ; Vol. 24, No. 5. pp. 761-767.
@article{20e8eb0d49db4ddf8f4cdbf2bd727ae2,
title = "Delays in diagnosis and treatment of breast cancer: A multinational analysis",
abstract = "Background: Reducing treatment delay improves outcomes in breast cancer. The aim of this study was to determine factors influencing patient- and system-related delays in commencing breast cancer treatment in different countries. Methods: A total of 6588 female breast cancer patients from 12 countries were surveyed. Total delay time was determined as the sum of the patient-related delay time (time between onset of the first symptoms and the first medical visit) and system-related delay time (time between the first medical visit and the start of therapy). Results: The average patient-related delay time and total delay time were 4.7 (range: 3.4-6.2) weeks and 14.4 (range: 11.5-29.4) weeks, respectively. Longer patient-related delay times were associated with distrust and disregard, and shorter patient-related delay times were associated with fear of breast cancer, practicing self-examination, higher education level, being employed, having support from friends and family and living in big cities. The average system-related delay time was 11.1 (range: 8.3-24.7) weeks. Cancer diagnosis made by an oncologist versus another physician, higher education level, older age, family history of female cancers and having a breast lump as the first cancer sign were associated with shorter system-related delay times. Longer patient-related delay times and higher levels of distrust and disregard were predictors of longer system-related delay times. Conclusions: The delay in diagnosis and treatment of breast cancer remains a serious problem. Several psychological and behavioural patient attributes strongly determine both patient-related delay time and system-related delay time, but their strength is different in particular countries.",
author = "Jacek Jassem and Vahit Ozmen and Florin Bacanu and Monika Drobniene and Janis Eglitis and Lakshmaiah, {Kuntegowdanahalli C.} and Z. Kah{\'a}n and Jozef Mardiak and Tadeusz Pieńkowski and Tatiana Semiglazova and Ljiljana Stamatovic and Constanta Timcheva and Suzana Vasovic and Damir Vrbanec and Piotr Zaborek",
year = "2014",
month = "10",
day = "1",
doi = "10.1093/eurpub/ckt131",
language = "English",
volume = "24",
pages = "761--767",
journal = "European Journal of Public Health",
issn = "1101-1262",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Delays in diagnosis and treatment of breast cancer

T2 - A multinational analysis

AU - Jassem, Jacek

AU - Ozmen, Vahit

AU - Bacanu, Florin

AU - Drobniene, Monika

AU - Eglitis, Janis

AU - Lakshmaiah, Kuntegowdanahalli C.

AU - Kahán, Z.

AU - Mardiak, Jozef

AU - Pieńkowski, Tadeusz

AU - Semiglazova, Tatiana

AU - Stamatovic, Ljiljana

AU - Timcheva, Constanta

AU - Vasovic, Suzana

AU - Vrbanec, Damir

AU - Zaborek, Piotr

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background: Reducing treatment delay improves outcomes in breast cancer. The aim of this study was to determine factors influencing patient- and system-related delays in commencing breast cancer treatment in different countries. Methods: A total of 6588 female breast cancer patients from 12 countries were surveyed. Total delay time was determined as the sum of the patient-related delay time (time between onset of the first symptoms and the first medical visit) and system-related delay time (time between the first medical visit and the start of therapy). Results: The average patient-related delay time and total delay time were 4.7 (range: 3.4-6.2) weeks and 14.4 (range: 11.5-29.4) weeks, respectively. Longer patient-related delay times were associated with distrust and disregard, and shorter patient-related delay times were associated with fear of breast cancer, practicing self-examination, higher education level, being employed, having support from friends and family and living in big cities. The average system-related delay time was 11.1 (range: 8.3-24.7) weeks. Cancer diagnosis made by an oncologist versus another physician, higher education level, older age, family history of female cancers and having a breast lump as the first cancer sign were associated with shorter system-related delay times. Longer patient-related delay times and higher levels of distrust and disregard were predictors of longer system-related delay times. Conclusions: The delay in diagnosis and treatment of breast cancer remains a serious problem. Several psychological and behavioural patient attributes strongly determine both patient-related delay time and system-related delay time, but their strength is different in particular countries.

AB - Background: Reducing treatment delay improves outcomes in breast cancer. The aim of this study was to determine factors influencing patient- and system-related delays in commencing breast cancer treatment in different countries. Methods: A total of 6588 female breast cancer patients from 12 countries were surveyed. Total delay time was determined as the sum of the patient-related delay time (time between onset of the first symptoms and the first medical visit) and system-related delay time (time between the first medical visit and the start of therapy). Results: The average patient-related delay time and total delay time were 4.7 (range: 3.4-6.2) weeks and 14.4 (range: 11.5-29.4) weeks, respectively. Longer patient-related delay times were associated with distrust and disregard, and shorter patient-related delay times were associated with fear of breast cancer, practicing self-examination, higher education level, being employed, having support from friends and family and living in big cities. The average system-related delay time was 11.1 (range: 8.3-24.7) weeks. Cancer diagnosis made by an oncologist versus another physician, higher education level, older age, family history of female cancers and having a breast lump as the first cancer sign were associated with shorter system-related delay times. Longer patient-related delay times and higher levels of distrust and disregard were predictors of longer system-related delay times. Conclusions: The delay in diagnosis and treatment of breast cancer remains a serious problem. Several psychological and behavioural patient attributes strongly determine both patient-related delay time and system-related delay time, but their strength is different in particular countries.

UR - http://www.scopus.com/inward/record.url?scp=84919790036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919790036&partnerID=8YFLogxK

U2 - 10.1093/eurpub/ckt131

DO - 10.1093/eurpub/ckt131

M3 - Article

VL - 24

SP - 761

EP - 767

JO - European Journal of Public Health

JF - European Journal of Public Health

SN - 1101-1262

IS - 5

ER -